An mHealth (Mobile Health) Intervention for Smoking Cessation in People With Tuberculosis: A Cluster Randomized Clinical Trial
Document Type
Article
Publication Date
1-1-2026
Abstract
Importance Smoking worsens outcomes in people with tuberculosis (TB), while quitting hastens recovery. Objective To assess the effectiveness of a mobile health (mHealth) intervention for achieving self-reported continuous tobacco abstinence at 6 months, supported by biochemical verification at 6 months, compared with usual care in people with TB. Design, Setting, and Participants Multicenter, cluster randomized clinical trial conducted between September 18, 2023, and January 2, 2025, randomizing (2:1) 27 TB clinics in Bangladesh and Pakistan to mHealth or usual care groups. The follow-up was 6 months. Participants were eligible if they were 15 years or older, had been diagnosed with drug-sensitive pulmonary TB in the past 4 weeks, smoked daily, were willing to quit, and had access to mobile phones. Intervention The mHealth group (n = 720) received text messages throughout TB treatment, daily for 2 months then monthly for 4 months, encouraging tobacco cessation. The usual care group (n = 360) received written information on tobacco cessation. Main Outcomes and Measures The primary outcome was self-reported continuous abstinence at 6 months, verified biochemically using carbon monoxide breath test at 6 months. Secondary outcomes included self-reported point abstinence at 9 weeks and 6 months, TB treatment adherence (days receiving TB treatment), TB treatment success (cured + completed treatment), TB treatment failure, TB treatment default (interruption of TB treatment for ≥2 months), and death. Results Of 9232 patients assessed for eligibility, 1080 were randomized; most were male (mHealth, 96.9%; usual care, 95.8%), and 985 were retained throughout the trial (91%). For the primary outcome, 300 of 720 participants (41.7%) in the mHealth group demonstrated self-reported and biochemically verified continuous abstinence at 6 months, compared with 55 of 360 (15.3%) in the usual care group (risk ratio, 3.0 [95% CI, 2.0-4.9]). In the mHealth vs usual care groups, respectively, mean TB treatment adherence was 174.3 (SD, 21.5) days vs 178.0 (SD, 12.1) days (P =.23), and treatment success was 89.3% vs 85.6% (risk ratio, 1.2 [95% CI, 0.9-1.6]). TB treatment failure (0.1% vs 0.5%) and default (3.1% vs 1.9%) were uncommon. Mortality was lower with mHealth (3.5%) vs usual care (7.5%) (hazard ratio, 0.4 [95%CI, 0.2-0.9]). Conclusions and Relevance An mHealth intervention was effective in achieving continuous abstinence in people with TB who smoked. mHealth is a feasible and effective intervention to help patients with TB quit smoking.
Keywords
Adult, Bangladesh, Female, Humans, Male, Middle Aged, Pakistan, Smoking Cessation, Telemedicine, Text Messaging, Tuberculosis, Tuberculosis, Pulmonary
Publication Title
JAMA
ISSN
0098-7484
DOI
10.1001/jama.2025.20765
Recommended Citation
Zahid, Maham; Rahman, Fahmidur; Danaee, Mahmoud; Rana, Shakhawat Hossain; Chowdhury, Asiful; Ansaari, Saeed; Lim, Ai Keow; Boeckmann, Melanie; Parrott, Steve; Li, Jinshuo; Khan, Amina; Huque, Rumana; Norrie, John; and Siddiqi, Kamran, "An mHealth (Mobile Health) Intervention for Smoking Cessation in People With Tuberculosis: A Cluster Randomized Clinical Trial" (2026). Research Publications (2026 to 2030). 2052.
https://knova.um.edu.my/research_publications_2026_2030/2052
Publisher
American Medical Association